Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 18.184% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. CCc1cccc(NC(=O)CCCN2C(=O)NC(C)(C)C2=O)c1
b. CCn1cc(C(=O)OCC(=O)Nc2c(C)cccc2C)c(=O)c2ccc(C)nc21
Answer: b. CCn1cc(C(=O)OCC(=O)Nc2c(C)cccc2C)c(=O)c2ccc(C)nc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCn1cc(C(=O)OCC(=O)Nc2c(C)cccc2C)c(=O)c2ccc(C)nc21
CCn1cc(C(=O)OCC(=O)Nc2c(C)cccc2C)c(=O)c2ccc(C)nc21
[2-(2,6-dimethylanilino)-2-oxoethyl] 1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylate